Drugs / CDX-0158
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02642016 | Dec 2015 → Jan 2018 | cancer of unknown primary site | Celldex Therapeutics | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CDX-0158 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02642016 ↗ |
| Known as | KTN-0158 | “CDX-0158 (formerly known as KTN-0158)” NCT02642016 ↗ |